Bayer completes refi as European loan volumes increase 22%
Pharmaceutical group Bayer has signed a Eu3.5bn revolving credit facility after the line was 70% oversubscribed, completing the fifth largest deal of the year so far as European syndicated lending continues to grow year on year.
According to data provider Dealogic, volumes in the European syndicated loan market reached $95.3bn in the first two months up the year, up 22% on the same period last year. However, volumes still fell short of the $125.6bn reached over January and February in 2009.
The number of
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: firstname.lastname@example.org or find out more online here.